The Midwest faces some of the highest obesity rates in the country, and Oak Park is no exception. With Michigan reporting 35.4% obesity prevalence and 11.6% diabetes, the need for effective GLP-1 treatment is urgent. Tirzepatide has shown average weight loss of 20-25% of body weight of body weight in clinical trials, and Weight Method makes it accessible to Oak Park residents through a fully virtual program.
GLP-1 treatment prescribed by licensed providers. Delivered to your door.
Free consultation · No commitment · Results in weeks
From 2,000+ patients · Oak Park is already seeing results
GLP-1 weight-loss treatment available to eligible patients in Oak Park, MI. Weight Method offers compounded tirzepatide, prescribed by licensed providers, from $329/month with virtual consultations and direct-to-door shipping.
For many people in Oak Park, diet and exercise alone have not produced lasting results — and that is not a failure of willpower. Tirzepatide (Mounjaro / Zepbound) addresses the hormonal drivers of excess weight, helping your body regulate appetite at the source. Weight Method's telehealth program brings this treatment to Michigan residents with a streamlined process: complete an online assessment, consult with a licensed provider, and receive your Tirzepatide shipped directly to your Oak Park address. Average weight loss in clinical trials is 20-25% of body weight of body weight over 12-18 months.
Suburban life around Oak Park comes with its own weight management challenges — car-dependent commutes, limited walkability, and the convenience of drive-throughs. Tirzepatide addresses the biology behind weight gain by reducing hunger signals and improving metabolic function, so Oak Park area residents can break patterns that willpower alone cannot fix. Weight Method prescribes Tirzepatide virtually, with medication delivered to your door.
Compounded GLP-1 medications dispensed by U.S.-licensed 503A pharmacies.

Compounded semaglutide. Once-weekly subcutaneous injection.

Compounded tirzepatide. Dual-action GLP-1/GIP, once-weekly subcutaneous injection.
Consult with a licensed provider in Michigan and start Tirzepatide from $329/month.
Get Started NowFree consultation. No commitment.